Tri-modal Imaging Instrument for Thyroid Cancer

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Thyroid NeoplasmsThyroid CancerThyroid Nodule
Interventions
DEVICE

Tri-modal imaging

This trimodal imaging system was developed in collaboration with Sogang University and is composed of three subsystems: ultrasound, photoacoustic and fluorescence. For this study, the fluorescence subsystem will not be used. The photoacoustic and ultrasound subsystems and data acquisition are controlled by a single workstation. The complete system is Canadian Standards Association (CSA) certified.

Trial Locations (1)

Unknown

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02758158 - Tri-modal Imaging Instrument for Thyroid Cancer | Biotech Hunter | Biotech Hunter